N-myristoylation regulates the axonal distribution of the Fragile X-related protein FXR2P

Molecular and Cellular Neuroscience

Volumn 62, Issue , 2014, Pages 42-50

  Stackpole, Emily E ^a   Akins, Michael R ^a,b   Fallon, Justin R ^a  

^a BROWN UNIVERSITY   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

Fragile X syndrome; FXR2P; Myristoylation; RNA binding proteins

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; FXR2P PROTEIN; GLYCINE; GLYCINE 2; LIPID; MUTANT PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; MICROTUBULE ASSOCIATED PROTEIN; MYRISTIC ACID DERIVATIVE; PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN CELL CULTURE; CHEMICAL MODIFICATION; CLICK CHEMISTRY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLUORESCENCE ANALYSIS; GROWTH CONE; MYRISTYLATION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; WILD TYPE; ANIMAL; BRAIN; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; FRAGILE X SYNDROME; GENETICS; METABOLISM; NERVE CELL; PROTEIN PROCESSING; ANIMAL EXPERIMENT; CELL GRANULE; CELLULAR DISTRIBUTION; FRAGILE X GRANULE; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; MOUSE; NERVE CELL CULTURE; PRESYNAPTIC NERVE; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; WESTERN BLOTTING;

ANIMALS; AXONS; BRAIN; CERCOPITHECUS AETHIOPS; COS CELLS; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; MICROTUBULE-ASSOCIATED PROTEINS; MYRISTATES; NEURONS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84906707915     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2014.08.003     Document Type: Article

References (54)

1. Aderem A.A., Albert K.A., Keum M.M., Wang J.K., Greengard P., Cohn Z.A. Stimulus-dependent myristoylation of a major substrate for protein kinase C. Nature 1988, 332:362-364.
2. Akins M.R., Berk-Rauch H.E., Fallon J.R. Presynaptic translation: stepping out of the postsynaptic structure. Front. Neural Circ. 2009, 3:17.
3. Akins M.R., Leblanc H.F., Stackpole E.E., Chyung E., Fallon J.R. Systematic mapping of fragile X granules in the mouse brain reveals a potential role for presynaptic FMRP in sensorimotor functions. J. Comp. Neurol. 2012, 520:3687-3706.
4. Antar L.N., Li C., Zhang H., Carroll R.C., Bassell G.J. Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol. Cell. Neurosci. 2006, 32:37-48.
5. Bagni C., Greenough W.T. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat. Rev. Neurosci. 2005, 6:376-387.
6. Bassell G.J., Warren S.T. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 2008, 60:201-214.
7. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004, 27:370-377.
8. Blackshear P.J. The MARCKS family of cellular protein kinase C substrates. J. Biol. Chem. 1993, 268:1501-1504.
9. Bramham C.R., Wells D.G. Dendritic mRNA: transport, translation, and function. Nat. Rev. Neurosci. 2007, 8:776-789.
10. 2-terminal blocking group of the catalytic subunit of cyclic AMP-dependent protein kinase from bovine cardiac muscle. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:6128-6131.
11. Christie S.B., Akins M.R., Schwob J.E., Fallon J.R. The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits. J. Neurosci. 2009, 29:1512-1524.
12. Cohen D., Pichard N., Tordjman S., Baumann C., Burglen L., Excoffier E., Lazar G., Mazet P., Pinquier C., Verloes A., et al. Specific genetic disorders and autism: clinical contribution towards their identification. J. Autism Dev. Disord. 2005, 35:103-116.
13. Cvetkovska V., Hibbert A.D., Emran F., Chen B.E. Overexpression of Down syndrome cell adhesion molecula impairs precise synaptic targeting. Nat. Neurosci. 2013, 16:677-682.
14. Darnell R.B. RNA protein interaction in neurons. Annu. Rev. Neurosci. 2013, 36:243-270.
15. Darnell J.C., Van Driesche S.J., Zhang C., Hung K.Y., Mele A., Fraser C.E., Stone E.F., Chen C., Fak J.J., Chi S.W., Licatalosi D.D., Richter J.D., Darnell R.B. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146:247-261.
16. Davidovic L., Jaglin X.H., Lepagnoi-Bestel A.M., Tremblay S., Simonneau M., Bardoni B., Khandjian E.W. The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules. Hum. Mol. Genet. 2007, 16:3047-3058.
17. Deng P.Y., Sojka D., Klyachko V.A. Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome. J. Neurosci. 2011, 31:10971-10982.
18. Deng P.Y., Rotman Z., Blundon J.A., Cho Y., Cui J., Cavalli V., Zakharenko S.S., Klyachko V.A. FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels. Neuron 2013, 77:696-711.
19. Feng Y., Gutekunst C.A., Eberhart D.E., Yi H., Warren S.T., Hersch S.M. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 1997, 17:1539-1547.
20. Ferron L., Nieto R.M., Cassidy J.S., Dolphin A.C. Fragile X mental retardation protein controls synaptic vesicle exocytosis by modulating N-type calcium channel density. Nat. Commun. 2014, 5:3628.
21. Frottin F., Martinez A., Peynot P., Mitra S., Holz R.C., Giglione C., Meinnel T. The proteomics of N-terminal methionine cleavage. Mol. Cell. Proteomics 2006, 5:2336-2349.
22. Gabel L.A., Won S., Kawai H., McKinney M., Tartakoff A.M., Fallon J.R. Visual experience regulates transient expression and dendritic localization of fragile X mental retardation protein. J. Neurosci. 2004, 24:10579-10583.
23. Garber K.B., Visootsak J., Warren S.T. Fragile X syndrome. Eur. J. Hum. Genet. 2008, 16:666-672.
24. Hanson J.E., Madison D.V. Presynaptic FMR1 genotype influences the degree of synaptic connectivity in a mosaic mouse model of fragile X syndrome. J. Neurosci. 2007, 27:4014-4018.
25. Heal W.P., Wright M.H., Thinon E., Tate E.W. Multifunction protein labeling via enzymatic N-terminal tagging and elaboration by click chemistry. Nat. Protoc. 2011, 7:105-117.
26. Hernandez R.N., Feinberg R.L., Vaurio R., Passanante N.M., Thompson R.E., Kaufmann W.E. Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation. Am. J. Med. Genet. A 2009, 149A:1125-1137.
27. James G., Olson E.N. Myristoylation, phosphorylation and subcellular distribution of the 80-kDa protein kinase C substrate in BC3H1 myocytes. J. Biol. Chem. 1989, 264:20928-20933.
28. Jung H., Yoon B.C., Holt C.E. Axonal mRNA localization and protein synthesis in nervous system assembly, maintenance and repair. Nat. Rev. Neurosci. 2012, 13:308-324.
29. Kapeli K., Yeo G.W. Genome-wide approaches to dissect the roles of RNA binding proteins in translational control: implications for neurological diseases. Front. Neurosci. 2012, 10.3389/fnins.2012.00144.
30. Kiebler M.A., Bassell G.J. Neuronal RNA granules: movers and makers. Neuron 2006, 51:685-690.
31. Kim J.H., Wang X., Coolon R., Ye B. Dscam expression levels determine presynaptic arbor sizes in Drosophila sensory neurons. Neuron 2013, 78:827-838.
32. Köhrmann M., Luo M., Kaether C., DesGroseillers L., Dotti C.G., Kiebler M.A. Microtubule-dependent recruitment of Staufen-green fluorescent protein into large RNA-containing granules and subsequent dendritic transport in living hippocampal neurons. Mol. Biol. Cell 1999, 10:2945-2953.
33. Levenga J., Buijsen R.A., Rife M., Moine H., Nelson D.L., Oostra B.A., Willemsen R., De Vrij F.M. Ultrastructural analysis of the functional domains in FMRP using primary hippocampal neurons. Neurobiol. Dis. 2009, 35:241-250.
34. Musil L.S., Carr C., Cohen J.B., Merlie J.P. Acetylcholine receptor-associated 43K protein contains covalently bound myristate. J. Cell Biol. 1988, 107:1113-1121.
35. O'Callaghan D.W., Tepikin A.V., Burgoyne R.D. Dynamics and calcium sensitivity of the Ca2+/myristoyl switch protein hippocalcin in living cells. J. Cell Biol. 2003, 163:715-721.
36. Palmer C.L., Lim W., Hastie P.G., Toward M., Korolchuk V.I., Burbridge S.A., Banting G., Collingridge G.L., Isaac J.T., Henley J.M. Hippocalcin functions as a calcium sensor in hippocampal LTD. Neuron 2005, 47:487-494.
37. Peitzsch R.M., McLaughlin S. Binding of acylated peptides and fatty acids to phospholipid vesicles: pertinence to myristoylated proteins. Biochemistry 1993, 32:10436-10443.
38. Pickett J., London E. The neuropathology of autism: a review. J. Neuropathol. Exp. Neurol. 2005, 64:925-935.
39. Price T.J., Flores C.M., Cervero F., Hargreaves K.M. The RNA binding and transport proteins staufen and fragile X mental retardation protein are expressed by rat primary afferent neurons and localize to peripheral and central axons. Neuroscience 2006, 141:2107-2116.
40. Resh M.D. Myristylation and palmitylation of Src family members: the fats of the matter. Cell 1994, 76:411-413.
41. Resh M.D. Membrane targeting of lipid modified signal transduction proteins. Subcell. Biochem. 2004, 37:217-232.
42. Sheridan D.L., Berlot C.H., Robert A., Inglis F.M., Jakobsdottir K.B., Howe J.R., Hughes T.E. A new way to rapidly create function, fluorescent fusion proteins: random insertion of GFP with an in vitro transposition reaction. BMC Neurosci 2002, 3.
43. Siomi H., Siomi M.C., Nussbaum R.L., Dreyfuss G. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 1993, 74:291-298.
44. Sorek N., Bloch D., Yalovsky S. Protein lipid modifications in signaling and subcellular targeting. Curr. Opin. Plant Biol. 2009, 12:714-720.
45. Spilker C., Dresbach T., Braunewell K.H. Reversible translocation and activity-dependent localization of the calcium-myristoyl switch protein VILIP-1 to different compartments in living hippocampal neurons. J. Neurosci. 2002, 22:7331-7339.
46. Takasaki A., Hayashi N., Matsubara M., Yamauchi E., Taniguchi H. Identification of the calmodulin-binding domain of neuron-specific protein kinase C substrate protein CAP-22/NAP-2. Direct involvement of protein myristoylation in calmodulin-target protein interaction. J. Biol. Chem. 1999, 274:11848-11853.
47. Tanaguchi H. Protein myristoylation in protein-lipid and protein-protein interactions. Biophys. Chem. 1999, 82:129-137.
48. Tessier C.R., Broadie K. Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning. Development 2008, 135:1547-1557.
49. Till S.M., Li H.L., Miniaci M.C., Kandel E.R., Choi Y.B. A presynaptic role for FMRP during protein synthesis-dependent long-term plasticity in Aplysia. Learn. Mem. 2010, 18:39-48.
50. Towler D.A., Eubanks S.R., Towery D.S., Adams S.P., Glaser L. Amino-terminal processing of proteins by N-myristoylation. Substrate specificity of N-myristoyl transferase. J. Biol. Chem. 1987, 262:1030-1036.
51. Towler D.A., Adams S.P., Eubanks S.R., Towery D.S., Jackson-Machelski E., Glaser L., Gordon J.I. Myristoyl CoA: protein N-myristoyltransferase activities from rat liver and yeast possess overlapping yet distinct peptide substrate specificities. J. Biol. Chem. 1988, 263:1784-1790.
52. Wilcox C., Hu J.S., Olson E.N. Acylation of proteins with myristic acid occurs cotranslationally. Science 1987, 27:1275-1278.
53. Zhang Y.Q., Bailey A.M., Matthles H.J., Renden R.B., Smith M.A., Speese S.D., Rubin G.M., Broadie K. Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell 2001, 107:591-603.
54. Zozulya S., Styer L. Calcium-myristoyl protein switch. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11569-11673.